EUVIMEDEUVIMED entdecken
Crossref

Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320

Kai Lu, Wanchao Zhang, Xiaoqiang Tang, Ruohan Yin, Tao Wang, Xiaoyu Wei, Changjie Pan

American Journal of Cancer Research · 2026 · 16 (10) · 4679-4682

DOI: 10.62347/jcct4943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Kai Lu und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lu, K., Zhang, W., Tang, X., Yin, R., Wang, T., Wei, X., & Pan, C. (2026). Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320. American Journal of Cancer Research, 16(10), 4679-4682. https://doi.org/10.62347/jcct4943

Vancouver

Lu K, Zhang W, Tang X, Yin R, Wang T, Wei X, et al. Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320. American Journal of Cancer Research. 2026;16(10):4679-4682. doi:10.62347/jcct4943

BibTeX
@article{Lu2026,
  author = {Lu, Kai and Zhang, Wanchao and Tang, Xiaoqiang and Yin, Ruohan and Wang, Tao and Wei, Xiaoyu and Pan, Changjie},
  title = {Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320},
  journal = {American Journal of Cancer Research},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {4679--4682},
  doi = {10.62347/jcct4943}
}
Kostenlos starten →